These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27023652)

  • 1. What are the latest recommendations for pneumococcal vaccines?
    Fabel PH; Horton EC; Shealy K
    JAAPA; 2016 Apr; 29(4):13-4. PubMed ID: 27023652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Kobayashi M; Bennett NM; Gierke R; Almendares O; Moore MR; Whitney CG; Pilishvili T
    MMWR Morb Mortal Wkly Rep; 2015 Sep; 64(34):944-7. PubMed ID: 26334788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal Vaccination Among Medicare Beneficiaries Occurring After the Advisory Committee on Immunization Practices Recommendation for Routine Use Of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults Aged ≥65 Years.
    Black CL; Williams WW; Warnock R; Pilishvili T; Kim D; Kelman JA
    MMWR Morb Mortal Wkly Rep; 2017 Jul; 66(27):728-733. PubMed ID: 28704347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Nuorti JP; Whitney CG;
    MMWR Recomm Rep; 2010 Dec; 59(RR-11):1-18. PubMed ID: 21150868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Developments and Future Directions of Pneumococcal Vaccine Recommendations.
    Tromp KM; Campbell MW; Vazquez A
    Clin Ther; 2015 May; 37(5):928-34. PubMed ID: 25913921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Oct; 61(40):816-9. PubMed ID: 23051612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Call to action on pneumococcal disease: review of vaccination evidence and outcomes of webcast programs.
    Grogg SE; Schultz J
    J Am Osteopath Assoc; 2015 Jun; 115(6 Suppl):S6-25. PubMed ID: 26000904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Tomczyk S; Bennett NM; Stoecker C; Gierke R; Moore MR; Whitney CG; Hadler S; Pilishvili T;
    MMWR Morb Mortal Wkly Rep; 2014 Sep; 63(37):822-5. PubMed ID: 25233284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23).
    ;
    MMWR Morb Mortal Wkly Rep; 2010 Sep; 59(34):1102-6. PubMed ID: 20814406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Care Physicians' Struggle with Current Adult Pneumococcal Vaccine Recommendations.
    Hurley LP; Allison MA; Pilishvili T; O'Leary ST; Crane LA; Brtnikova M; Beaty BL; Lindley MC; Bridges CB; Kempe A
    J Am Board Fam Med; 2018; 31(1):94-104. PubMed ID: 29330244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Updates to the Advisory Committee On Immunization Practices Recommendations for Pneumococcal and Herpes Zoster Vaccination.
    Brotherton AL; Shah R
    R I Med J (2013); 2020 Aug; 103(6):34-37. PubMed ID: 32752563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumococcal conjugate vaccine update.
    Campos-Outcalt D
    J Fam Pract; 2019 Dec; 68(10):564-566. PubMed ID: 31860700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(9):258-61. PubMed ID: 20224542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Licensure of 13-valent pneumococcal conjugate vaccine for adults aged 50 years and older.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Jun; 61(21):394-5. PubMed ID: 22647745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Advisory Committee on Immunization Practices
    MMWR Recomm Rep; 2000 Oct; 49(RR-9):1-35. PubMed ID: 11055835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumococcal disease prevention among adults: Strategies for the use of pneumococcal vaccines.
    Pilishvili T; Bennett NM
    Vaccine; 2015 Nov; 33 Suppl 4():D60-5. PubMed ID: 26116257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naïve adults 60-64 years of age.
    Greenberg RN; Gurtman A; Frenck RW; Strout C; Jansen KU; Trammel J; Scott DA; Emini EA; Gruber WC; Schmoele-Thoma B
    Vaccine; 2014 Apr; 32(20):2364-74. PubMed ID: 24606865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization update: This year's changes.
    Campos-Outcalt D
    J Fam Pract; 2016 Mar; 65(3):198-200. PubMed ID: 27158692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal Perplexity: Improving Awareness of Updated Pneumococcal Vaccination Recommendations in Two Large Military Treatment Facilities.
    Pacheco CS; Baxter JA; Steigelman D
    Mil Med; 2024 May; 189(5-6):e1289-e1293. PubMed ID: 38554258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.
    Jackson LA; Gurtman A; Rice K; Pauksens K; Greenberg RN; Jones TR; Scott DA; Emini EA; Gruber WC; Schmoele-Thoma B
    Vaccine; 2013 Aug; 31(35):3585-93. PubMed ID: 23688527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.